Approval builds on established role of Rhapsido in CSU and highlights potential of BTK inhibition across immune-mediated ...
Novartis achieved Tier 1 status in the 2026 Corporate Mental Health Benchmark, recognizing its approach to workplace mental ...
About Novartis Neuroscience Neurological diseases are deeply personal, affecting people of any age, from newborns to seniors, often striking in the prime of life. In multiple sclerosis (MS), Novartis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results